PE20020792A1 - Antagonistas de receptores de aminoacidos excitadores - Google Patents

Antagonistas de receptores de aminoacidos excitadores

Info

Publication number
PE20020792A1
PE20020792A1 PE2002000003A PE2002000003A PE20020792A1 PE 20020792 A1 PE20020792 A1 PE 20020792A1 PE 2002000003 A PE2002000003 A PE 2002000003A PE 2002000003 A PE2002000003 A PE 2002000003A PE 20020792 A1 PE20020792 A1 PE 20020792A1
Authority
PE
Peru
Prior art keywords
alkyl
refers
acid
antagonists
amino acid
Prior art date
Application number
PE2002000003A
Other languages
English (en)
Spanish (es)
Inventor
Michael Edward Letourneau
Khau Vien Van
Michael John Martinelli
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PE20020792A1 publication Critical patent/PE20020792A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PE2002000003A 2001-01-05 2002-01-04 Antagonistas de receptores de aminoacidos excitadores PE20020792A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26001401P 2001-01-05 2001-01-05

Publications (1)

Publication Number Publication Date
PE20020792A1 true PE20020792A1 (es) 2002-09-06

Family

ID=22987455

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2002000003A PE20020792A1 (es) 2001-01-05 2002-01-04 Antagonistas de receptores de aminoacidos excitadores

Country Status (23)

Country Link
EP (1) EP1351955A1 (hr)
JP (1) JP2004520335A (hr)
KR (1) KR20030066797A (hr)
CN (1) CN1484642A (hr)
AR (1) AR035679A1 (hr)
BR (1) BR0116672A (hr)
CA (1) CA2431545A1 (hr)
CZ (1) CZ20031856A3 (hr)
DZ (1) DZ3460A1 (hr)
EA (1) EA200300770A1 (hr)
EC (1) ECSP034682A (hr)
HR (1) HRP20030544A2 (hr)
HU (1) HUP0302528A2 (hr)
IL (1) IL156138A0 (hr)
MX (1) MXPA03005981A (hr)
NO (1) NO20032973D0 (hr)
NZ (1) NZ525821A (hr)
PE (1) PE20020792A1 (hr)
PL (1) PL361934A1 (hr)
SK (1) SK8242003A3 (hr)
TW (1) TW591023B (hr)
WO (1) WO2002053561A1 (hr)
ZA (1) ZA200304311B (hr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284957A (en) * 1992-09-03 1994-02-08 Eli Lilly And Company Excitatory amino acid receptor antagonists
KR20010040711A (ko) * 1998-02-06 2001-05-15 피터 기딩스 파록세틴의 염
GB9908175D0 (en) * 1999-04-09 1999-06-02 Lilly Co Eli Method of treating neurological disorders
EP1200073B1 (en) * 1999-07-06 2007-01-10 Eli Lilly And Company SELECTIVE iGluR 5? RECEPTOR ANTAGONISTS FOR THE TREATMENT OF MIGRAINE

Also Published As

Publication number Publication date
KR20030066797A (ko) 2003-08-09
PL361934A1 (en) 2004-10-18
SK8242003A3 (en) 2004-01-08
CZ20031856A3 (cs) 2003-09-17
CA2431545A1 (en) 2002-07-11
MXPA03005981A (es) 2003-09-10
IL156138A0 (en) 2003-12-23
JP2004520335A (ja) 2004-07-08
HRP20030544A2 (en) 2004-08-31
ZA200304311B (en) 2004-09-02
HUP0302528A2 (hu) 2003-11-28
NO20032973L (no) 2003-06-27
ECSP034682A (es) 2003-08-29
BR0116672A (pt) 2003-09-23
TW591023B (en) 2004-06-11
NO20032973D0 (no) 2003-06-27
NZ525821A (en) 2004-07-30
EA200300770A1 (ru) 2003-10-30
DZ3460A1 (fr) 2002-07-11
WO2002053561A1 (en) 2002-07-11
AR035679A1 (es) 2004-06-23
EP1351955A1 (en) 2003-10-15
CN1484642A (zh) 2004-03-24

Similar Documents

Publication Publication Date Title
AU754716B2 (en) Amide derivatives and nociceptin antagonists
PE20230249A1 (es) Compuestos de heteroarilo biciclicos y usos de estos
ES2702474T3 (es) Ciclohexilmetanosulfonamidas
PE20120418A1 (es) DERIVADOS DE PIRIDO[2,3-b]PIRAZINA COMO INHIBIDORES DE POLI (ADP-RIBOSA) POLIMERASA (PARP)
EP2138489B1 (en) Novel pyrimidine compound having benzyl(heterocyclicmethyl)amine structure and pharmaceutical product containing the same
HK1098460A1 (en) Fused hetrocyclic compounds and their use as metabotropic receptor antagonists for the treatment of gastrointestinal disorders
AR053566A1 (es) Compuestos espiriciclicos antagonistas de los receptores de trombina
PE20060570A1 (es) Compuestos de quinazolina e isoquinolina piperidilo sustituidos como inhibidores de fosfodiesterasa pde-10
WO2006050007A3 (en) Substituted indolizines and derivatives as cns agents
WO2009050242A3 (de) Heterocyclus-substituierte piperazino-dihydrothienopyrimidine
ECSP088293A (es) Inhibidores de gamma secretasa, de sulfonamido n-cíclico puenteado
ES2966369T3 (es) Compuestos y métodos para el tratamiento de enfermedades parasitarias
AR054611A1 (es) Antagonistas del receptor de trombina y composicion farmaceutica
BRPI0408988A (pt) composto de piperidinilamino-tieno[2,3-d]pirimidina
WO2008077557A8 (en) 8-ethinylxanthine derivatives as selective a2a receptor antagonists
NO985518L (no) Morfinanderivater og medisinsk anvendelse derav
DE602006004882D1 (de) Azabicycloä3.1.0ühexylphenylderivate als modulatoren von dopamin-d3-rezeptoren
ATE399770T1 (de) Tachykininrezeptorantagonisten
TW200519096A (en) Quinazoline analogs as receptor tyrosine kinase inhibitors
EA200200952A1 (ru) Производные циклогексиламина в качестве селективных антагонистов подтипов nmda-рецепторов
PE20080176A1 (es) Compuestos de arilpiperazina sulfonamida como agonista de los receptores de secretagogos de la hormona de crecimiento (ghs)
BR0206495A (pt) Tratamento de distúrbios de cns empregando antagonistas de oxidase de d-aminoácido e oxidase de d-aspartato
PE20060533A1 (es) Derivados de dicetopiperazina como antagonistas del receptor de oxitocina
EA200201158A1 (ru) Бициклические циклогексиламины и их применение в качестве антагонистов nmda-рецепторов
DE60227576D1 (de) 3,6-DISUBSTITUIERTE AZABICYCLO i3.1.0 -HEXANDERIVATIVE ALS ANTAGONISTEN DES MUSCARINREZEPTORS

Legal Events

Date Code Title Description
FC Refusal